02/06

2021

On February 3, Shanghai Yangguang Pharmaceutical Purchasing Network officially released the bidding results of fourth batch of national volume based procurement. Jiangxi Shanxiang Pharmaceutical Co...

11/16

2020

On November 4, Xinkang® Lacosamide injection, declared by Jiangxi Qingfeng Pharmaceutical Co., Ltd., was approved by NMPA and deemed to have passed the consistency evaluation. This is the first ...

09/17

2020

On September 10, Shanghai Denovo PharmaceuticalTechnology Co., Ltd., a subsidiary of Qingfeng Pharmaceutical Group, held aTLR8 agonist DN1508052-01 Phase I clinical trial kick-off meeting at Shangh...
NEWS
R&D

Innovation Platform

R&D Talents

R&D Results

Research Cooperation
Qingfeng Pharmaceutical Group Co.Ltd
Location:8 Zhandong Av., Zhanggong, Ganzhou, Jiangxi Province, China
Phone:+86-0797-5560800,5560600 Fax: +86-0797-5560620